271 related articles for article (PubMed ID: 27072111)
1. The application of proteomics in different aspects of hepatocellular carcinoma research.
Xing X; Liang D; Huang Y; Zeng Y; Han X; Liu X; Liu J
J Proteomics; 2016 Aug; 145():70-80. PubMed ID: 27072111
[TBL] [Abstract][Full Text] [Related]
2. Proteomics for the early detection and treatment of hepatocellular carcinoma.
Feng JT; Shang S; Beretta L
Oncogene; 2006 Jun; 25(27):3810-7. PubMed ID: 16799622
[TBL] [Abstract][Full Text] [Related]
3. Precision Medicine: Update on Diagnosis and Therapeutic Strategies of Hepatocellular Carcinoma.
Liang Q; Shen X; Sun G
Curr Med Chem; 2018; 25(17):1999-2008. PubMed ID: 29345573
[TBL] [Abstract][Full Text] [Related]
4. Prognostic biomarkers for prediction of recurrence of hepatocellular carcinoma: current status and future prospects.
Lee SC; Tan HT; Chung MC
World J Gastroenterol; 2014 Mar; 20(12):3112-24. PubMed ID: 24696598
[TBL] [Abstract][Full Text] [Related]
5. Reveal the molecular signatures of hepatocellular carcinoma with different sizes by iTRAQ based quantitative proteomics.
Wang Y; Liu H; Liang D; Huang Y; Zeng Y; Xing X; Xia J; Lin M; Han X; Liao N; Liu X; Liu J
J Proteomics; 2017 Jan; 150():230-241. PubMed ID: 27693406
[TBL] [Abstract][Full Text] [Related]
6. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature.
Qin LX; Tang ZY
J Cancer Res Clin Oncol; 2004 Sep; 130(9):497-513. PubMed ID: 15205947
[TBL] [Abstract][Full Text] [Related]
7. [Stable isotope labeling and parallel reaction monitoring-based proteomic quantification for biomarker screening and validation of hepatocellular carcinoma].
Wang S; Gao H; Zhang J; Ye X
Se Pu; 2017 Sep; 35(9):934-940. PubMed ID: 29048850
[TBL] [Abstract][Full Text] [Related]
8. Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids.
Okajima W; Komatsu S; Ichikawa D; Miyamae M; Ohashi T; Imamura T; Kiuchi J; Nishibeppu K; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2017 Aug; 23(31):5650-5668. PubMed ID: 28883691
[TBL] [Abstract][Full Text] [Related]
9. [Proteomic-driven precision medicine research in hepatocellular carcinoma].
Jiang Y; He FC
Zhonghua Gan Zang Bing Za Zhi; 2022 Aug; 30(8):797-802. PubMed ID: 36207935
[TBL] [Abstract][Full Text] [Related]
10. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
Peng XQ; Wang F; Geng X; Zhang WM
Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
[TBL] [Abstract][Full Text] [Related]
11. One Sample, One Shot - Evaluation of sample preparation protocols for the mass spectrometric proteome analysis of human bile fluid without extensive fractionation.
Megger DA; Padden J; Rosowski K; Uszkoreit J; Bracht T; Eisenacher M; Gerges C; Neuhaus H; Schumacher B; Schlaak JF; Sitek B
J Proteomics; 2017 Feb; 154():13-21. PubMed ID: 27932303
[TBL] [Abstract][Full Text] [Related]
12. In-depth proteomic analysis of tissue interstitial fluid for hepatocellular carcinoma serum biomarker discovery.
Zhang J; Hao N; Liu W; Lu M; Sun L; Chen N; Wu M; Zhao X; Xing B; Sun W; He F
Br J Cancer; 2017 Nov; 117(11):1676-1684. PubMed ID: 29024941
[TBL] [Abstract][Full Text] [Related]
13. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
Chiou SH; Lee KT
Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
[TBL] [Abstract][Full Text] [Related]
14. Oncoproteomics of hepatocellular carcinoma: from cancer markers' discovery to functional pathways.
Sun S; Lee NP; Poon RT; Fan ST; He QY; Lau GK; Luk JM
Liver Int; 2007 Oct; 27(8):1021-38. PubMed ID: 17845530
[TBL] [Abstract][Full Text] [Related]
15. Challenges of Clinical Research on Hepatocellular Carcinoma.
Kudo M; Kitano M; Sakurai T; Nishida N
Dig Dis; 2015 Oct; 33(6):780-90. PubMed ID: 26488399
[TBL] [Abstract][Full Text] [Related]
16. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review.
Kimhofer T; Fye H; Taylor-Robinson S; Thursz M; Holmes E
Br J Cancer; 2015 Mar; 112(7):1141-56. PubMed ID: 25826224
[TBL] [Abstract][Full Text] [Related]
17. Tissue-based quantitative proteome analysis of human hepatocellular carcinoma using tandem mass tags.
Megger DA; Rosowski K; Ahrens M; Bracht T; Eisenacher M; Schlaak JF; Weber F; Hoffmann AC; Meyer HE; Baba HA; Sitek B
Biomarkers; 2017 Mar; 22(2):113-122. PubMed ID: 27467182
[TBL] [Abstract][Full Text] [Related]
18. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
[TBL] [Abstract][Full Text] [Related]
19. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.
Black AP; Mehta AS
Curr Opin Pharmacol; 2018 Aug; 41():74-78. PubMed ID: 29772420
[TBL] [Abstract][Full Text] [Related]
20. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
Masuda T; Miyoshi E
Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
